Walleye Trading Advisors »

Candel Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $419k 41k 10.30

More positions owned by Walleye Trading Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust St Str P500etf (SPYM)
Amazon (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Echostar Corp Note 3.875%11/3 (Principal)
Apple (AAPL)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Applied Materials (AMAT)
Cisco Systems (CSCO)

View all positions for Walleye Trading Advisors

Top funds holding Candel Therapeutics

FMR
Rtw Investments
BlackRock
Acorn Capital Advisors
Portolan Capital Management
Saturn V Capital Management
Vanguard Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
Halter Ferguson Financial
Northern Trust
Kennedy Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Candel Therapeutics